tiprankstipranks
Sarepta Therapeutics (SRPT)
NASDAQ:SRPT

Sarepta Therapeutics (SRPT) Ownership - Who Owns Sarepta Therapeutics?

2,907 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 11, 2024Sold$93550
Mar 11, 2024Sold$1848795
Mar 06, 2024
Stephen Mayo
Director
Sold$385480
Mar 05, 2024Sold$200019

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2024Bought$231215
Mar 31, 2024Bought$512143
Mar 31, 2024Sold$2225935
Mar 31, 2024Bought$2332998

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
8,323,500Institution8.81%1,304,708,625
7,747,927Institution8.20%1,214,487,557
6,151,560Institution6.51%964,257,030
3,181,688Insider3.37%498,729,594
2,962,520Institution3.13%464,375,010
2,890,239Institution3.06%453,044,963
2,453,500Institution2.60%384,586,125
1,914,236Institution2.03%300,056,493
1,887,675Institution2.00%295,893,056
1,580,418Institution1.67%247,730,522

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
7,747,927Institution8.20%1,214,487,557
2,962,520Institution3.13%464,375,010
1,914,236Institution2.03%300,056,493
1,887,675Institution2.00%295,893,056
1,580,418Institution1.67%247,730,522
1,540,079Institution1.63%241,407,383
998,571Institution1.06%156,526,004
943,881Institution1.00%147,953,347
896,200Institution0.95%140,479,350
776,314Institution0.82%121,687,220

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,945,048Institution3.12%461,636,274
2,806,349Institution2.97%364,432,481
2,267,429Institution2.40%294,448,330
1,492,740Institution1.58%235,852,920
1,412,111Institution1.49%183,376,734
1,288,847Institution1.36%167,369,671
758,996Institution0.80%118,972,623
658,400Institution0.70%103,204,200
513,728Institution0.54%80,526,864
491,811Institution0.52%77,091,374

FAQ

Who Owns Sarepta Therapeutics (SRPT)?
Currently, no data Available
What percentage of Sarepta Therapeutics (SRPT) stock is held by institutional investors?
Currently, no data Available
What percentage of Sarepta Therapeutics (SRPT) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Sarepta Therapeutics (SRPT)?
Vanguard owns the most shares of Sarepta Therapeutics (SRPT).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis